Monday, September 15, 2025 - Portland, ME

Bispecific Antibodies in the Outpatient Setting:

Yoni Resnick, PharmD

Director of Pharmacy Clinical Services

New England Cancer Specialists

This nursing continuing professional development activity has been approved by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Postponed! Rescheduled date TBA.

Updates on Management of Prostate Cancer: What's New in 2025

Praful Ravi, MB BChir MRCP

Medical Director of GU Theranostics and Assistant Professor of Medicine
Dana-Farber Cancer Institute